S132 An Interim Analysis of a Phase 3, Open-Label Study Indicates Efficacy and Safety of RBX2660 in Patients With Recurrent Clostridioides difficile Infection
Khanna, Sahil, Dubberke, Erik R., Knapple, Whitfield L., Feuerstadt, Paul, Assi, Maha, Ng, Samson, Guthmueller, Beth
Published in The American journal of gastroenterology (01.10.2022)
Published in The American journal of gastroenterology (01.10.2022)
Get full text
Journal Article
S195 Efficacy and Safety of Fecal Microbiota, Live-jslm in Older Participants With Recurrent Clostridioides difficile Infection and Underlying Comorbidities: An Ad Hoc Analysis of an Open-Label, Phase 3 Study
Warren, Cirle A., Tillotson, Glenn, Guthmueller, Beth, Thul, Joan, Feuerstadt, Paul, Gonzales-Luna, Anne J., Carlson, Travis J.
Published in The American journal of gastroenterology (01.10.2023)
Published in The American journal of gastroenterology (01.10.2023)
Get full text
Journal Article
Safety of fecal microbiota, live-jslm (REBYOTA™) in individuals with recurrent Clostridioides difficile infection: data from five prospective clinical trials
Lee, Christine, Louie, Thomas, Bancke, Lindy, Guthmueller, Beth, Harvey, Adam, Feuerstadt, Paul, Khanna, Sahil, Orenstein, Robert, Dubberke, Erik R.
Published in Therapeutic advances in gastroenterology (01.01.2023)
Published in Therapeutic advances in gastroenterology (01.01.2023)
Get full text
Journal Article
Final Results from a Phase 2b Randomized, Placebo-Controlled Clinical Trial of RBX2660: A Microbiota-Based Drug for the Prevention of Recurrent Clostridioides difficile Infection
Dubberke, Erik R., Orenstein, Robert, Khanna, Sahil, Guthmueller, Beth, Lee, Christine
Published in Infectious diseases and therapy (01.02.2023)
Published in Infectious diseases and therapy (01.02.2023)
Get full text
Journal Article
S159 Efficacy and Safety of RBX2660 in Reducing Recurrent Clostridioides difficile Infection in Patients With Underlying Gastrointestinal Comorbidities
Khanna, Sahil, Dubberke, Erik R., Knapple, Whitfield L., Feuerstadt, Paul, Assi, Maha, Ng, Samson, Guthmueller, Beth, Ando, Masakazu
Published in The American journal of gastroenterology (01.10.2022)
Published in The American journal of gastroenterology (01.10.2022)
Get full text
Journal Article
Sa1901 EFFICACY AND SAFETY OF FECAL MICROBIOTA, LIVE-JSLM IN PARTICIPANTS WITH RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION RECEIVING CONCOMITANT MEDICATIONS
Tillotson, Glenn S., Feuerstadt, Paul, Carlson, Travis J., Guthmueller, Beth, Martinez, Anthony, Reveles, Kelly
Published in Gastroenterology (New York, N.Y. 1943) (18.05.2024)
Published in Gastroenterology (New York, N.Y. 1943) (18.05.2024)
Get full text
Journal Article
700 SAFETY AND EFFICACY OF RBX2660 IN REDUCING RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION IN IMMUNOCOMPROMISED PARTICIPANTS
Dubberke, Erik R., Fischer, Monika, Tillotson, Glenn S., Bidell, Monique, Guthmueller, Beth, Hoeyer, Frederikke, Alonso, Carolyn D.
Published in Gastroenterology (New York, N.Y. 1943) (01.05.2023)
Published in Gastroenterology (New York, N.Y. 1943) (01.05.2023)
Get full text
Journal Article
1042. Safety of Investigational Microbiota-Based Live Biotherapeutic RBX2660 in Individuals with Recurrent Clostridioides difficile Infection: Data from Five Prospective Clinical Studies
Braun, Tricia, Guthmueller, Beth, Harvey, Adam J
Published in Open forum infectious diseases (04.12.2021)
Published in Open forum infectious diseases (04.12.2021)
Get full text
Journal Article
PUNCH CD3-OLS: a phase 3 prospective observational cohort study to evaluate the safety and efficacy of fecal microbiota, live-jslm (REBYOTA) in adults with recurrent Clostridioides difficile infection
Feuerstadt, Paul, Chopra, Teena, Knapple, Whitfield, Van Hise, Nicholas W, Dubberke, Erik R, Baggott, Brian, Guthmueller, Beth, Bancke, Lindy, Gamborg, Michael, Steiner, Theodore S, Van Handel, Daniel, Khanna, Sahil
Published in Clinical infectious diseases (24.08.2024)
Published in Clinical infectious diseases (24.08.2024)
Get more information
Journal Article
Fecal Microbiota, Live-jslm for the Prevention of Recurrent Clostridioides difficile Infection : Subgroup Analysis of PUNCH CD2 and PUNCH CD3
Feuerstadt, Paul, Crawford, Carl V, Tan, Xing, Pokhilko, Victoria, Bancke, Lindy, Ng, Samson, Guthmueller, Beth, Bidell, Monique R, Tillotson, Glenn, Johnson, Stuart, Skinner, Andrew M
Published in Journal of clinical gastroenterology (01.09.2024)
Published in Journal of clinical gastroenterology (01.09.2024)
Get more information
Journal Article
Quality of Life Increased After Treatment for Participants in a Phase 2B Randomized, Double-Blinded, Placebo-Controlled Clinical Trial of RBX2660 for Preventing Recurrent Clostridium difficile Infections: 2739
Guthmueller, Beth, Orenstein, Robert, Dubberke, Erik, Khanna, Sahil, Gerding, Dale, Mische, Sarah, Jones, Courtney, Blount, Ken
Published in The American journal of gastroenterology (01.10.2018)
Published in The American journal of gastroenterology (01.10.2018)
Get full text
Journal Article
706. An Ad Hoc Subgroup Analysis of a Phase 3, Open-Label Study Indicates Efficacy and Safety of Fecal Microbiota, Live-jslm in Participants With Recurrent Clostridioides difficile Infection and Renal Impairment
Fischer, Monika, Thul, Joan, Guthmueller, Beth, Sandrock, Christian, Van Hise, Nicholas, Tillotson, Glenn S
Published in Open forum infectious diseases (27.11.2023)
Published in Open forum infectious diseases (27.11.2023)
Get full text
Journal Article
Safety of fecal microbiota, live-jslm (REBYOTA) in individuals with recurrent infection: data from five prospective clinical trials
Christine Lee, Thomas Louie, Lindy Bancke, Beth Guthmueller, Adam Harvey, Paul Feuerstadt, Sahil Khanna, Robert Orenstein, Erik R. Dubberke
Published in Therapeutic advances in gastroenterology (01.06.2023)
Published in Therapeutic advances in gastroenterology (01.06.2023)
Get full text
Journal Article
702. Efficacy of Fecal Microbiota, Live-jslm After Receipt of Non–Clostridioides difficile Infection Antibiotics: Post Hoc Subgroup Analysis of a Phase 2 Open-Label Trial
Reveles, Kelly R, Gonzales-Luna, Anne J, Golan, Yoav, Alonso, Carolyn D, Guthmueller, Beth, Tan, Xing, Bidell, Monique, Pokhilko, Victoria, Crawford, Carl, Skinner, Andrew M
Published in Open forum infectious diseases (27.11.2023)
Published in Open forum infectious diseases (27.11.2023)
Get full text
Journal Article
Efficacy of Fecal Microbiota, Live-jslm (REBYOTA®), Among Patients Exposed to Non–Clostridioides difficile Infection Antibiotics: Post Hoc Subgroup Analysis of a Phase 2 Open-Label Study
Reveles, Kelly R, Gonzales-Luna, Anne J, Golan, Yoav, Alonso, Carolyn D, Guthmueller, Beth, Tan, Xing, Bidell, Monique R, Pokhilko, Victoria, Crawford, Carl V, Skinner, Andrew M
Published in Open forum infectious diseases (01.07.2024)
Published in Open forum infectious diseases (01.07.2024)
Get full text
Journal Article